{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:28Z","timestamp":1786982848160,"version":"build-2736575974"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01792-9","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T05:01:59Z","timestamp":1699506119000},"page":"1487-1496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single-dose antithymocyte globulin in standard immunological risk kidney transplant recipients: efficacy and kinetics of peripheral blood CD3+ T lymphocyte modulation"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-0891","authenticated-orcid":false,"given":"Fabiani P.","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5061-2633","authenticated-orcid":false,"given":"Nicole","family":"Rauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-152X","authenticated-orcid":false,"given":"Alessandra R.","family":"Vicari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5041-4792","authenticated-orcid":false,"given":"Andrea C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-3734","authenticated-orcid":false,"given":"Roberto C.","family":"Manfro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"6","key":"1792_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1159\/000351643","volume":"37","author":"UM Thiyagarajan","year":"2013","unstructured":"Thiyagarajan UM, Ponnuswamy A, Bagul A (2013) Thymoglobulin and its use in renal transplantation: a review. Am J Nephrol 37(6):586\u2013601. https:\/\/doi.org\/10.1159\/000351643","journal-title":"Am J Nephrol"},{"issue":"4","key":"1792_CR2","doi-asserted-by":"publisher","first-page":"eAO4278","DOI":"10.31744\/einstein_journal\/2018AO4278","volume":"16","author":"FP Machado","year":"2018","unstructured":"Machado FP, Vicari AR, Spuldaro F, de Castro JBS, Manfro RC (2018) Polyclonal anti T-lymphocyte antibody therapy monitoring in kidney transplant recipients: comparison of CD3+ T cell and total lymphocyte counts. Einstein S\u00e3o Paulo 16(4):eAO4278. https:\/\/doi.org\/10.31744\/einstein_journal\/2018AO4278","journal-title":"Einstein S\u00e3o Paulo"},{"issue":"5","key":"1792_CR3","doi-asserted-by":"publisher","first-page":"E450","DOI":"10.1111\/ctr.12021","volume":"26","author":"G Mourad","year":"2012","unstructured":"Mourad G, Morelon E, No\u00ebl C, Glotz D, Lebranchu Y (2012) The role of thymoglobulin induction in kidney transplantation: an update. Clin Transpl 26(5):E450-464. https:\/\/doi.org\/10.1111\/ctr.12021","journal-title":"Clin Transpl"},{"issue":"3","key":"1792_CR4","first-page":"319","volume":"2","author":"AD Moicean","year":"2009","unstructured":"Moicean AD, Popp AM, Sinescu I (2009) Thymoglobulin\u2013new approaches to optimal outcomes. J Med Life 2(3):319\u2013324","journal-title":"J Med Life"},{"issue":"1","key":"1792_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1590\/s1679-45082011ao1838","volume":"9","author":"LRR Moura","year":"2011","unstructured":"Moura LRR et al (2011) Immunological induction with thymoglobulin: reduction in the number of doses in renal transplant from deceased donor. Einstein S\u00e3o Paulo 9(1):56\u201365. https:\/\/doi.org\/10.1590\/s1679-45082011ao1838","journal-title":"Einstein S\u00e3o Paulo"},{"key":"1792_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1672621","volume":"2018","author":"C Dopazo","year":"2018","unstructured":"Dopazo C et al (2018) Low total dose of anti-human T-lymphocyte globulin (ATG) guarantees a good glomerular filtration rate after liver transplant in recipients with pretransplant renal dysfunction. Can J Gastroenterol Hepatol 2018:1\u20137. https:\/\/doi.org\/10.1155\/2018\/1672621","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"1792_CR7","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/ajt.13327","volume":"15","author":"H Tedesco-Silva","year":"2015","unstructured":"Tedesco-Silva H et al (2015) Reduced incidence of cytomegalovirus infection in kidney transplant recipients receiving everolimus and reduced tacrolimus doses: reduced CMV infection with everolimus. Am J Transpl 15(10):2655\u20132664. https:\/\/doi.org\/10.1111\/ajt.13327","journal-title":"Am J Transpl"},{"issue":"9","key":"1792_CR8","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"9","key":"1792_CR9","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","volume":"20","author":"A Loupy","year":"2020","unstructured":"Loupy A et al (2020) The banff 2019 kidney meeting report (I): updates on and clarification of criteria for T cell\u2013 and antibody-mediated rejection. Am J Transpl 20(9):2318\u20132331. https:\/\/doi.org\/10.1111\/ajt.15898","journal-title":"Am J Transpl"},{"issue":"9","key":"1792_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1097\/00007890-200205150-00025","volume":"73","author":"VR Peddi","year":"2002","unstructured":"Peddi VR, Bryant M, Roy-Chaudhury P, Woodle ES, First MR (2002) Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation 73(9):1514\u20131518","journal-title":"Transplantation"},{"issue":"1","key":"1792_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2257.1997.00210.x","volume":"19","author":"M Gorrie","year":"1997","unstructured":"Gorrie M et al (1997) Dose titration during anti-thymocyte globulin therapy: monitoring by CD3 count or total lymphocyte count? Clin Lab Haematol 19(1):53\u201356","journal-title":"Clin Lab Haematol"},{"issue":"8","key":"1792_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1432-2277.2006.00270.x","volume":"19","author":"W Wong","year":"2006","unstructured":"Wong W et al (2006) Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation. Transpl Int 19(8):629\u2013635. https:\/\/doi.org\/10.1111\/j.1432-2277.2006.00270.x","journal-title":"Transpl Int"},{"issue":"4","key":"1792_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.trim.2012.02.003","volume":"26","author":"MML Kho","year":"2012","unstructured":"Kho MML, Bouvy AP, Cadogan M, Kraaijeveld R, Baan CC, Weimar W (2012) The effect of low and ultra-low dosages thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol 26(4):186\u2013190. https:\/\/doi.org\/10.1016\/j.trim.2012.02.003","journal-title":"Transpl Immunol"},{"issue":"11","key":"1792_CR14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/00007890-199506150-00010","volume":"59","author":"GM Abouna","year":"1995","unstructured":"Abouna GM et al (1995) Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring. Transplantation 59(11):1564\u20131568","journal-title":"Transplantation"},{"issue":"5","key":"1792_CR15","first-page":"2817","volume":"28","author":"M Buchler","year":"1996","unstructured":"Buchler M et al (1996) Monitoring of ATG therapy by flow cytometry and lymphocyte counts in renal transplantation. Transpl Proc 28(5):2817\u20132818","journal-title":"Transpl Proc"},{"key":"1792_CR16","doi-asserted-by":"publisher","DOI":"10.5935\/0101-2800.20170032","author":"G Furlanetto","year":"2017","unstructured":"Furlanetto G, Alegretti AP, Farias MG, Freitas PAC, Lara GM, Pedrazzani FS (2017) Cut-off value for absolute lymphocytes as an alternative for the immunophenotypic analysis of CD3+ T cells in the monitoring of immunosuppressive therapy with thymoglobulin. J Bras Nefrol. https:\/\/doi.org\/10.5935\/0101-2800.20170032","journal-title":"J Bras Nefrol"},{"issue":"3","key":"1792_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.transproceed.2013.02.092","volume":"45","author":"P Ata","year":"2013","unstructured":"Ata P et al (2013) Monitoring of CD3+ T-Cell count in patients receiving antithymocyte globulin induction after cadaveric renal transplantation. Transpl Proc 45(3):929\u2013931. https:\/\/doi.org\/10.1016\/j.transproceed.2013.02.092","journal-title":"Transpl Proc"},{"issue":"4","key":"1792_CR18","doi-asserted-by":"publisher","first-page":"S455","DOI":"10.1016\/j.healun.2020.01.290","volume":"39","author":"R Jackson","year":"2020","unstructured":"Jackson R, Heyrend C, Fullerton C, Benefield E, Ensign R, Molina K (2020) Safety and efficacy of CD3 guided anti-thymocyte globulin dosing after pediatric heart transplant. J Heart Lung Transpl 39(4):S455. https:\/\/doi.org\/10.1016\/j.healun.2020.01.290","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"1792_CR19","doi-asserted-by":"publisher","first-page":"e0251384","DOI":"10.1371\/journal.pone.0251384","volume":"16","author":"K Linhares","year":"2021","unstructured":"Linhares K et al (2021) The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation. PLoS ONE 16(5):e0251384. https:\/\/doi.org\/10.1371\/journal.pone.0251384","journal-title":"PLoS ONE"},{"issue":"10","key":"1792_CR20","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1097\/TP.0000000000003124","volume":"104","author":"MI de Paula","year":"2020","unstructured":"de Paula MI et al (2020) The influence of antithymocyte globulin dose on the incidence of CMV infection in high-risk kidney transplant recipients without pharmacological prophylaxis. Transplantation 104(10):2139\u20132147. https:\/\/doi.org\/10.1097\/TP.0000000000003124","journal-title":"Transplantation"},{"issue":"8","key":"1792_CR21","doi-asserted-by":"publisher","first-page":"e104408","DOI":"10.1371\/journal.pone.0104408","volume":"9","author":"M Grafals","year":"2014","unstructured":"Grafals M et al (2014) Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. PLoS ONE 9(8):e104408. https:\/\/doi.org\/10.1371\/journal.pone.0104408","journal-title":"PLoS ONE"},{"issue":"6","key":"1792_CR22","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/tri.13865","volume":"34","author":"TV Sandes-Freitas","year":"2021","unstructured":"Sandes-Freitas TV et al (2021) Exploring the causes of the high incidence of delayed graft function after kidney transplantation in Brazil: a multicenter study. Transpl Int 34(6):1093\u20131104. https:\/\/doi.org\/10.1111\/tri.13865","journal-title":"Transpl Int"},{"key":"1792_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.12659\/AOT.890069","volume":"19","author":"D Chen","year":"2014","unstructured":"Chen D (2014) Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience. Ann Transp 19:277\u2013282. https:\/\/doi.org\/10.12659\/AOT.890069","journal-title":"Ann Transp"},{"issue":"19","key":"1792_CR24","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa060068","volume":"355","author":"DC Brennan","year":"2006","unstructured":"Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D (2006) Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355(19):1967\u20131977. https:\/\/doi.org\/10.1056\/NEJMoa060068","journal-title":"N Engl J Med"},{"issue":"2","key":"1792_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.transproceed.2007.01.024","volume":"39","author":"P Clesca","year":"2007","unstructured":"Clesca P et al (2007) Thymoglobulin and rate of infectious complications after transplantation. Transplant Proc 39(2):463\u2013464. https:\/\/doi.org\/10.1016\/j.transproceed.2007.01.024","journal-title":"Transplant Proc"},{"issue":"2","key":"1792_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/tri.13800","volume":"34","author":"MI Paula","year":"2021","unstructured":"Paula MI et al (2021) Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis \u2013 a cohort single-center study. Transpl Int 34(2):339\u2013352. https:\/\/doi.org\/10.1111\/tri.13800","journal-title":"Transpl Int"},{"issue":"10","key":"1792_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/TP.0b013e3181f7c053","volume":"90","author":"H-T Kuo","year":"2010","unstructured":"Kuo H-T, Ye X, Sampaio MS, Reddy P, Bunnapradist S (2010) Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis. Transplantation 90(10):1091\u20131098. https:\/\/doi.org\/10.1097\/TP.0b013e3181f7c053","journal-title":"Transplantation"},{"issue":"8","key":"1792_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/01.tp.0000204048.90367.97","volume":"81","author":"AM Doyle","year":"2006","unstructured":"Doyle AM, Warburton KM, Goral S, Blumberg E, Grossman RA, Bloom RD (2006) 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course. Transplantation 81(8):1106\u20131111. https:\/\/doi.org\/10.1097\/01.tp.0000204048.90367.97","journal-title":"Transplantation"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01792-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01792-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01792-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:59Z","timestamp":1777564439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/6\/1487\/8306784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01792-9","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"28 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have read and understood\u00a0Journal of Nephrology's policy on disclosing conflicts of interest and declare that we have none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee approved the study under registration CAAE ID: 38361620000005327. The study is registered in the Clinical trials registry (ClinicalTrials.gov\u2014NCT04835948).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki in human research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate"}},{"value":"Data sharing anonymized data will be shared upon reasonable request to the corresponding author.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to publish"}}]}}